Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 56, Issue 6, 2007, Pages 1921-1933

  Dieker, Jürgen W ^a   Fransen, Justin H ^a   Van Bavel, Casandra C ^a   Briand, Jean Paul ^b   Jacobs, Cor W ^a   Muller, Sylviane ^b   Berden, Jo H ^a   Van Der Vlag, Johan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; HISTONE; HISTONE H4; IMMUNOGLOBULIN G; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; MONOCLONAL ANTIBODY;

ACETYLATION; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN DEPOSITION; MIXED LYMPHOCYTE REACTION; MORTALITY; MOUSE; NONHUMAN; NUCLEOSOME; PHAGE DISPLAY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEINURIA; STATISTICAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL STRAIN U937; CHROMATIN; CYTOLOGY; IMMUNE SYSTEM; IMMUNOLOGY; LEUKEMIA CELL LINE; METABOLISM; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

ACETYLATION; ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; AUTOANTIBODIES; CHROMATIN; DENDRITIC CELLS; EPITOPES; HISTONES; HUMANS; IMMUNE SYSTEM; JURKAT CELLS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED BALB C; MICE, INBRED MRL LPR; NUCLEOSOMES; T-LYMPHOCYTES; U937 CELLS;

EID: 34447523785     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22646     Document Type: Article

References (55)

1. Burlingame RW, Boey ML, Starkebaum G, Rubin RL. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 1994;94:184-92.
2. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
3. Berden JH. Lupus nephritis. Kidney Int 1997;52:538-58.
4. Kramers C, Hylkema MN, van Bruggen MC, van de Lagemaat R, Dijkman HB, Assmann KJ, et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 1994;94:568-77.
5. Licht R, van Bruggen MC, Oppers-Walgreen B, Rijke TP, Berden JH. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolysaccharide administration. Arthritis Rheum 2001;44:1320-30.
6. Rumore PM, Steinman CR. Endogenous circulating DNA in systemic lupus erythematosus: occurrence as multimeric complexes bound to histone. J Clin Invest 1990;86:69-74.
7. Dieker JW, van der Vlag J, Berden JH. Deranged removal of apoptotic cells: its role in the genesis of lupus. Nephrol Dial Transplant 2004;19:282-5.
8. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses [review]. Nat Rev Immunol 2002;2:965-75.
9. Dieker JW, van der Vlag J, Berden JH. Triggers for antichromatin autoantibody production in SLE [review]. Lupus 2002;11:856-64.
10. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1241-50.
11. Gaipl US, Kuhn A, Sheriff A, Munoz LE, Franz S, Voll RE, et al. Clearance of apoptotic cells in human SLE [review]. Curr Dir Autoimmun 2006;9:173-87.
12. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179:1317-30.
13. Radic M, Marion T, Monestier M. Nucleosomes are exposed at the cell surface in apoptosis. J Immunol 2004;172:6692-700.
14. Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999;190:815-26.
15. Utz PJ, Gensler TJ, Anderson P. Death, autoantigen modifications, and tolerance [review]. Arthritis Res 2000;2:101-14.
16. Doyle HA, Mamula MJ. Posttranslational modifications of self-antigens [review]. Ann N Y Acad Sci 2005;1050:1-9.
17. Peterson CL, Laniel MA. Histones and histone modifications [review]. Curr Biol 2004;14:R546-51.
18. Bondanza A, Zimmermann VS, Dell'Antonio G, Cin ED, Balestrieri G, Tincani A, et al. Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthritis Rheum 2004;50:1549-60.
19. Fournel S, Neichel S, Dali H, Farci S, Maillere B, Briand JP, et al. CD4+ T cells from (New Zealand Black x New Zealand White)F1 lupus mice and normal mice immunized against apoptotic nucleosomes recognize similar Th cell epitopes in the C terminus of histone H3. J Immunol 2003;171:636-44.
20. Mevorach D, Zhou JL, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998;188:387-92.
21. Van Bruggen MC, Kramers C, Walgreen B, Elema JD, Kallenberg CG, van den Born J, et al. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis. Nephrol Dial Transplant 1997;12:57-66.
22. Van der Heijden GW, Dieker JW, Derijck AA, Muller S, Berden JH, Braat DD, et al. Asymmetry in histone H3 variants and lysine methylation between paternal and maternal chromatin of the early mouse zygote. Mech Dev 2005;122:1008-22.
23. Dieker JW, Sun YJ, Jacobs CW, Putterman C, Monestier M, Muller S, et al. Mimotopes for lupus-derived anti-DNA and nucleosome-specific autoantibodies selected from random peptide phage display libraries: facts and follies. J Immunol Methods 2005;296:83-93.
24. Decker P, Singh-Jasuja H, Haager S, Kotter I, Rammensee HG. Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation. J Immunol 2005;174:3326-34.
25. Van Bruggen MC, Walgreen B, Rijke TP, Corsius MJ, Assmann KJ, Smeenk RJ, et al. Heparin and heparinoids prevent the binding of immune complexes containing nucleosomal antigens to the GBM and delay nephritis in MRL/lpr mice. Kidney Int 1996;50:1555-64.
26. Emmer PM, van der Vlag J, Adema GJ, Hilbrands LB. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. Transplantation 2006;81:1451-9.
27. Cheung WL, Ajiro K, Samejima K, Kloc M, Cheung P, Mizzen CA, et al. Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell 2003;113:507-17.
28. Fernandez-Capetillo O, Allis CD, Nussenzweig A. Phosphorylation of histone H2B at DNA double-strand breaks. J Exp Med 2004;199:1671-7.
29. Huggins ML, Todd I, Cavers MA, Pavuluri SR, Tighe PJ, Powell RJ. Antibodies from systemic lupus erythematosus (SLE) sera define differential release of autoantigens from cell lines undergoing apoptosis. Clin Exp Immunol 1999;118:322-8.
30. Allera C, Lazzarini G, Patrone E, Alberti I, Barboro P, Sanna P, et al. The condensation of chromatin in apoptotic thymocytes shows a specific structural change. J Biol Chem 1997;272:10817-22.
31. Hendzel MJ, Nishioka WK, Raymond Y, Allis CD, Bazett-Jones DP, Th'ng JP. Chromatin condensation is not associated with apoptosis. J Biol Chem 1998;273:24470-8.
32. Ikura T, Ogryzko VV, Grigoriev M, Groisman R, Wang J, Horikoshi M, et al. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 2000;102:463-73.
33. Rouaux C, Jokic N, Mbebi C, Boutillier S, Loeffler JP, Boutillier AL. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J 2003;22:6537-49.
34. Wang D, Lippard SJ. Cisplatin-induced post-translational modification of histones H3 and H4. J Biol Chem 2004;279:20622-5.
35. Murr R, Loizou JI, Yang YG, Cuenin C, Li H, Wang ZQ, et al. Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks. Nat Cell Biol 2006;8:91-9.
36. Bernhard D, Skvortsov S, Tinhofer I, Hubl H, Greil R, Csordas A, et al. Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts. Cell Death Differ 2001;8:1014-21.
37. Kim MS, Baek JH, Chakravarty D, Sidransky D, Carrier F. Sensitization to UV-induced apoptosis by the histone deacetylase inhibitor trichostatin A (TSA). Exp Cell Res 2005;306:94-102.
38. Insinga A, Monestiroli S, Ronzoni S, Gelmetti V, Marchesi F, Viale A, et al. Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway. Nat Med 2005;11:71-6.
39. Eberharter A, Becker PB. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep 2002;3:224-9.
40. Garcia BA, Busby SA, Shabanowitz J, Hunt DF, Mishra N. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition. J Proteome Res 2005;4:2032-42.
41. Mishra N, Reilly CM, Brown DR, Ruiz P, Gilkeson GS. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J Clin Invest 2003;111:539-52.
42. Martelli AM, Zweyer M, Ochs RL, Tazzari PL, Tabellini G, Narducci P, et al. Nuclear apoptotic changes: an overview. J Cell Biochem 2001;82:634-46.
43. Utz PJ, Hottelet M, Schur PH, Anderson P. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997;185:843-54.
44. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-81.
45. Monneaux F, Muller S. Peptide-based immunotherapy of systemic lupus erythematosus. Autoimmun Rev 2004;3:16-24.
46. Marushige Y, Marushige K. Disappearance of ubiquitinated histone H2A during chromatin condensation in TGF β 1-induccd apoptosis. Anticancer Res 1995;15:267-72.
47. Lu L, Kaliyaperumal A, Boumpas DT, Datta SK. Major peptide autoepitopes for nucleosome-specific T cells of human lupus. J Clin Invest 1999;104:345-55.
48. Christenscn SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, Shlomchik MJ. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 2005;202:321-31.
49. Waters ST, McDuffie M, Bagavant H, Deshmukh US, Gaskin F, Jiang C, et al. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med 2004;199:255-64.
50. Moudgil KD, Sercarz EE. Understanding crypticity is the key to
51. revealing the pathogenesis of autoimmunity. Trends Immunol 2005;26:355-9.
52. Jenuwein T, Allis CD. Translating the histone code. Science 2001;293:1074-80.
53. Kang HK, Michaels MA, Berner BR, Datta SK. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets. J Immunol 2005;174:3247-55.
54. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited [published erratum appears in J Am Soc Nephrol 2004;15:835-6]. J Am Soc Nephrol 2004;15:241-50.
55. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.